Developer docs
API playgroundTry for free, no card

Search company profiles

Argo Pond

Full company profile

uuid002iwu6

Namestring
Argo Pond
Legal namestring
ArgoPond, LLC
Websiteurl
argopond.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

ArgoPond, LLC is a privately held, founder-owned life sciences advisory and governance practice founded in 2014 by John G. Younger, MD and headquartered in Bala Cynwyd, Pennsylvania. The firm provides strategic counsel and fiduciary governance advisory at the intersection of biomedical innovation, capital allocation, and health system strategy. Its core services include early-stage investment diligence, governance assessment, corporate wind-down planning (notably the proprietary Administrative Fume Date framework), and Directors and Officers insurance policy assessment for distressed life sciences companies. Underlying the offerings are no proprietary software or technology products; the value proposition rests on senior advisory judgment grounded in the founder's combined clinical, C-suite restructuring, and federal research-policy experience.

The firm serves institutional clients across three verticals: (i) early-stage and venture-backed life sciences companies requiring diligence and governance support, (ii) distressed life sciences companies and their boards facing insolvency or restructuring, and (iii) federal agencies and academic medical centers — including the NIH, NSF, the U.S. House Committee on Small Business, the University of Pennsylvania, and Children's Hospital of Philadelphia — which the firm advises on research-policy and innovation-pipeline topics. ArgoPond operates on a professional-services revenue model with likely project-based or retainer engagements, accessed primarily through direct inquiries to the founder and professional referrals. Distribution is therefore constrained to founder-led enterprise relationships rather than a structured sales motion.

ArgoPond's geographic reach spans North America (its primary market), Europe (e.g., Cilcare Therapeutics), and Asia (Duke-NUS Singapore). The firm sustains a recurring thought-leadership presence through published briefings and reprints on topics including pediatric orthopaedic investment trends, sepsis start-up capital flows, wind-down planning, and D&O coverage — which double as a top-of-funnel content channel. The firm is small (1–10 employees listed), has no external institutional investors, and shows no evidence of fundraising, M&A, or material headcount expansion in the source data.

Short descriptiontext

ArgoPond is a privately held life sciences advisory firm providing strategic counsel, fiduciary governance, corporate wind-down planning, and D&O insurance assessment to early-stage biotechs, distressed life sciences companies, federal agencies, and academic medical centers, led by founder John G. Younger, MD.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBala Cynwyd, United States
HQ citystring
Bala Cynwyd
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
life sciences advisory, biotech governance consulting, startup wind-down planning, D&O insurance assessment, federal research policy advisory
Industry1 code
1Enterprise Risk Management (ERM) Advisory
CodeBPAHAFAAPrimaryYes
NAICS code3 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Administrative Management and General Management Consulting Services541611
SIC code2 codes
  • Services-Management Consulting Services8742
  • Investment Advice6282
Product category
Life Sciences Advisory and Governance Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Advisory Services
TypeProfessional Services
Description

Strategic counsel and fiduciary governance advisory services delivered to life science companies, health systems, academic institutions, and federal agencies. Revenue generated through professional service engagements, likely project-based or retainer arrangements.

argopond.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ArgoPond is a life sciences advisory and governance practice providing strategic counsel to early-stage biotech companies, distressed ventures, health systems, academic medical centers, and federal research institutions. Core service lines include early-stage diligence, investment and governance advisory, corporate wind-down planning with administrative fume date analysis, D&O insurance policy assessment for distressed companies, and federal research and policy infrastructure advisory. Engagements are delivered as customized professional service projects or retainer arrangements led by the firm's founder.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ArgoPond is an advisory firm, not a software product company. It offers a unified suite of life sciences advisory services including strategic counsel, fiduciary governance, corporate wind-down planning, and D&O insurance policy assessment. These services are advisory-based consulting offerings rather than software products or modules.

Product and service4 records
1Life Sciences Advisory Services
CategoryManagement Consulting / Life Sciences Strategy Advisory
Description

Strategic counsel and fiduciary governance services for early-stage life science ventures, covering early-stage diligence, investment governance, capital allocation decisions, and operational restructuring during financial distress. The engagement serves life science companies, venture and growth investors, health systems, academic medical centers, and federal agencies.

2Corporate Wind-Down Planning
CategoryRestructuring and Wind-Down Advisory
Description

Advisory engagements helping boards and executives plan and execute controlled corporate wind-downs, including administrative fume date calculation, liability enumeration, runway math that accounts for wind-down expenses, and fiduciary risk mitigation for directors and officers. Targeted at life science companies approaching insolvency and the advisors, receivers, and counsel who serve them.

3D&O Insurance Policy Assessment
CategoryRisk and Insurance Advisory
Description

A practical framework and accompanying advisory engagement evaluating the structural overlap between D&O coverage limits, exclusion language, and director liability for life science companies at the onset of financial distress or regulatory enforcement, with explicit attention to coverage Sides A, B, and C, exclusions, and payment prioritization among competing claims.

4Federal Research and Policy Infrastructure Advisory
CategoryPublic Policy and Federal Research Advisory
Description

Advisory services for federal agencies and congressional committees covering federal SBIR/STTR funding mechanism design, technology transfer bottlenecks, regional biotech ecosystem development, and academic-to-commercial translation pathways. Confirmed engagements include the U.S. House Committee on Small Business, the National Institutes of Health, and the National Science Foundation.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Life sciences strategy consulting firm focused on pharmaceutical, biotech, and medical device clients across commercial, R&D, and corporate strategy. Comparable boutique life science advisory with similar depth and client profile.

TypeDirect peer
Description

Life sciences advisory firm providing transaction advisory and strategic consulting to biotech and medtech clients. Highly comparable given its boutique advisory model focused on capital markets and strategic transactions for life science companies.

TypeBroad incumbent
Description

Large global management consulting firm with a substantial life sciences practice covering strategy, commercialization, and operations for pharma and biotech clients. Overlaps with ArgoPond's strategic counsel scope but at much greater scale.

TypeBroad incumbent
Description

Global advisory firm with a Health Solutions practice covering turnaround, restructuring, and governance for healthcare and life science companies. Overlaps with ArgoPond's wind-down and fiduciary governance advisory scope.

TypeBroad incumbent
Description

Global consulting firm with a Life Sciences practice providing strategic and economic advisory to pharma, biotech, and medical device clients. Comparable on strategic advisory to life science companies, though significantly larger and broader in scope.

TypeDirect peer
Description

Boston-based life science strategy and transaction advisory firm serving biotech, medtech, and digital health clients on commercial strategy, financing, and BD. Directly comparable as a boutique life sciences advisory practice serving early-stage and growth-stage companies.

TypeDirect peer
Description

Strategy consulting firm exclusively focused on healthcare and life sciences, advising on commercial strategy, M&A, and licensing. Comparable as a specialized life sciences strategy consultancy serving similar institutional clients.

TypeBroad incumbent
Description

Global professional services firm with a dedicated Life Sciences and Restructuring practice that advises distressed life science companies on wind-downs, turnaround, and D&O matters. Comparable on distressed-advisory content but much broader and larger than ArgoPond.

TypeBroad incumbent
Description

Life sciences strategy advisory and analytics firm providing strategic counsel to biopharma clients. Comparable in life science strategic advisory scope though larger and more commercially oriented.

TypeDirect peer
Description

Restructuring and turnaround advisory firm serving distressed and underperforming companies, with relevant experience in life sciences wind-downs and D&O assessments. Directly comparable on distressed-advisory and receivership support.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Argo Pond

Life Sciences Advisory and Governance Servicesargopond.com

ArgoPond is a privately held life sciences advisory firm providing strategic counsel, fiduciary governance, corporate wind-down planning, and D&O insurance assessment to early-stage biotechs, distressed life sciences companies, federal agencies, and academic medical centers, led by founder John G. Younger, MD.

What Argo Pond does

ArgoPond, LLC is a privately held, founder-owned life sciences advisory and governance practice founded in 2014 by John G. Younger, MD and headquartered in Bala Cynwyd, Pennsylvania. The firm provides strategic counsel and fiduciary governance advisory at the intersection of biomedical innovation, capital allocation, and health system strategy. Its core services include early-stage investment diligence, governance assessment, corporate wind-down planning (notably the proprietary Administrative Fume Date framework), and Directors and Officers insurance policy assessment for distressed life sciences companies. Underlying the offerings are no proprietary software or technology products; the value proposition rests on senior advisory judgment grounded in the founder's combined clinical, C-suite restructuring, and federal research-policy experience.

The firm serves institutional clients across three verticals: (i) early-stage and venture-backed life sciences companies requiring diligence and governance support, (ii) distressed life sciences companies and their boards facing insolvency or restructuring, and (iii) federal agencies and academic medical centers — including the NIH, NSF, the U.S. House Committee on Small Business, the University of Pennsylvania, and Children's Hospital of Philadelphia — which the firm advises on research-policy and innovation-pipeline topics. ArgoPond operates on a professional-services revenue model with likely project-based or retainer engagements, accessed primarily through direct inquiries to the founder and professional referrals. Distribution is therefore constrained to founder-led enterprise relationships rather than a structured sales motion.

ArgoPond's geographic reach spans North America (its primary market), Europe (e.g., Cilcare Therapeutics), and Asia (Duke-NUS Singapore). The firm sustains a recurring thought-leadership presence through published briefings and reprints on topics including pediatric orthopaedic investment trends, sepsis start-up capital flows, wind-down planning, and D&O coverage — which double as a top-of-funnel content channel. The firm is small (1–10 employees listed), has no external institutional investors, and shows no evidence of fundraising, M&A, or material headcount expansion in the source data.

Argo Pond firmographics

Firmographics
Name
Argo Pond
Legal name
ArgoPond, LLC
Website
https://argopond.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
ArgoPond is a privately held life sciences advisory firm providing strategic counsel, fiduciary governance, corporate wind-down planning, and D&O insurance assessment to early-stage biotechs, distressed life sciences companies, federal agencies, and academic medical centers, led by founder John G. Younger, MD.
Ownership category
akta.pro rank

Argo Pond industry classification

Industry
Product category
Life Sciences Advisory and Governance Services
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618), Administrative Management and General Management Consulting Services (541611)
SIC
Services-Management Consulting Services (8742), Investment Advice (6282)
akta.pro primary industry
Enterprise Risk Management (ERM) Advisory (BPAHAFAA)

Keywords

  • Life sciences advisory
  • Biotech governance consulting
  • Startup wind-down planning
  • D&O insurance assessment
  • Federal research policy advisory

Where Argo Pond is headquartered

Location

Headquarters

HQ city
Bala Cynwyd
HQ country
United States
HQ region
North America

Markets served

Argo Pond business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Advisory Services: Strategic counsel and fiduciary governance advisory services delivered to life science companies, health systems, academic institutions, and federal agencies. Revenue generated through professional service engagements, likely project-based or retainer arrangements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Argo Pond product offering

Product offering

Core offering

ArgoPond is a life sciences advisory and governance practice providing strategic counsel to early-stage biotech companies, distressed ventures, health systems, academic medical centers, and federal research institutions. Core service lines include early-stage diligence, investment and governance advisory, corporate wind-down planning with administrative fume date analysis, D&O insurance policy assessment for distressed companies, and federal research and policy infrastructure advisory. Engagements are delivered as customized professional service projects or retainer arrangements led by the firm's founder.

Product overview

ArgoPond is an advisory firm, not a software product company. It offers a unified suite of life sciences advisory services including strategic counsel, fiduciary governance, corporate wind-down planning, and D&O insurance policy assessment. These services are advisory-based consulting offerings rather than software products or modules.

Differentiator

Problem solved

Functional benefit

Products and services

  • Life Sciences Advisory Services Strategic counsel and fiduciary governance services for early-stage life science ventures, covering early-stage diligence, investment governance, capital allocation decisions, and operational restructuring during financial distress. The engagement serves life science companies, venture and growth investors, health systems, academic medical centers, and federal agencies.
  • Corporate Wind-Down Planning Advisory engagements helping boards and executives plan and execute controlled corporate wind-downs, including administrative fume date calculation, liability enumeration, runway math that accounts for wind-down expenses, and fiduciary risk mitigation for directors and officers. Targeted at life science companies approaching insolvency and the advisors, receivers, and counsel who serve them.
  • D&O Insurance Policy Assessment A practical framework and accompanying advisory engagement evaluating the structural overlap between D&O coverage limits, exclusion language, and director liability for life science companies at the onset of financial distress or regulatory enforcement, with explicit attention to coverage Sides A, B, and C, exclusions, and payment prioritization among competing claims.
  • Federal Research and Policy Infrastructure Advisory Advisory services for federal agencies and congressional committees covering federal SBIR/STTR funding mechanism design, technology transfer bottlenecks, regional biotech ecosystem development, and academic-to-commercial translation pathways. Confirmed engagements include the U.S. House Committee on Small Business, the National Institutes of Health, and the National Science Foundation.

Companies that use Argo Pond

Customer profile

Segments3 records

Ideal customer profiles4 records

Argo Pond technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Argo Pond partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Argo Pond competitors and assessment

Company assessment

Direct peers

  • ClearView Healthcare Partners: Life sciences strategy consulting firm focused on pharmaceutical, biotech, and medical device clients across commercial, R&D, and corporate strategy. Comparable boutique life science advisory with similar depth and client profile.
  • Locust Walk: Life sciences advisory firm providing transaction advisory and strategic consulting to biotech and medtech clients. Highly comparable given its boutique advisory model focused on capital markets and strategic transactions for life science companies.
  • Back Bay Life Science Advisors: Boston-based life science strategy and transaction advisory firm serving biotech, medtech, and digital health clients on commercial strategy, financing, and BD. Directly comparable as a boutique life sciences advisory practice serving early-stage and growth-stage companies.
  • Health Advances: Strategy consulting firm exclusively focused on healthcare and life sciences, advising on commercial strategy, M&A, and licensing. Comparable as a specialized life sciences strategy consultancy serving similar institutional clients.
  • Conway MacKenzie (now part of Riveron): Restructuring and turnaround advisory firm serving distressed and underperforming companies, with relevant experience in life sciences wind-downs and D&O assessments. Directly comparable on distressed-advisory and receivership support.

Broad incumbents

  • ZS Associates: Large global management consulting firm with a substantial life sciences practice covering strategy, commercialization, and operations for pharma and biotech clients. Overlaps with ArgoPond's strategic counsel scope but at much greater scale.
  • FTI Consulting: Global advisory firm with a Health Solutions practice covering turnaround, restructuring, and governance for healthcare and life science companies. Overlaps with ArgoPond's wind-down and fiduciary governance advisory scope.
  • Charles River Associates: Global consulting firm with a Life Sciences practice providing strategic and economic advisory to pharma, biotech, and medical device clients. Comparable on strategic advisory to life science companies, though significantly larger and broader in scope.
  • Alvarez & Marsal: Global professional services firm with a dedicated Life Sciences and Restructuring practice that advises distressed life science companies on wind-downs, turnaround, and D&O matters. Comparable on distressed-advisory content but much broader and larger than ArgoPond.
  • Trinity Life Sciences: Life sciences strategy advisory and analytics firm providing strategic counsel to biopharma clients. Comparable in life science strategic advisory scope though larger and more commercially oriented.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Argo Pond social profiles

Digital presence

Argo Pond financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Argo Pond leadership team

Management profile

Number of profiles

Profiles1 record

Argo Pond funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Argo Pond M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Argo Pond

What does Argo Pond do?

ArgoPond is a life sciences advisory and governance practice providing strategic counsel to early-stage biotech companies, distressed ventures, health systems, academic medical centers, and federal research institutions. Core service lines include early-stage diligence, investment and governance advisory, corporate wind-down planning with administrative fume date analysis, D&O insurance policy assessment for distressed companies, and federal research and policy infrastructure advisory. Engagements are delivered as customized professional service projects or retainer arrangements led by the firm's founder.

Is Argo Pond a public or private company?

Argo Pond is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Argo Pond founded?

Argo Pond was founded in 2014. It employs 1 to 10 people.

Where is Argo Pond based?

Argo Pond is headquartered in Bala Cynwyd, United States, in the North America region.

How does Argo Pond make money?

One revenue line is on record: advisory Services.

Who are Argo Pond's main competitors?

Direct peers on record are ClearView Healthcare Partners, Locust Walk, Back Bay Life Science Advisors, Health Advances and Conway MacKenzie (now part of Riveron). Broad incumbents are ZS Associates, FTI Consulting, Charles River Associates, Alvarez & Marsal and Trinity Life Sciences.

Does Argo Pond have an API?

No public API is recorded for Argo Pond.

What industry is Argo Pond in?

Argo Pond's product category is Life Sciences Advisory and Governance Services. Its primary akta.pro industry code is BPAHAFAA, Enterprise Risk Management (ERM) Advisory. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales